Allowed Publications
Slot System
Featured Buckets
Featured Buckets Admin

Antidepressants and Bleeding Risk

Article Type
Changed
Display Headline
Antidepressants and Bleeding Risk

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 21(1)
Publications
Topics
Page Number
37
Legacy Keywords
adverse drug effects and interactions, mental health, serotonergic antidepressants, surgery, bleedingadverse drug effects and interactions, mental health, serotonergic antidepressants, surgery, bleeding
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 21(1)
Issue
Federal Practitioner - 21(1)
Page Number
37
Page Number
37
Publications
Publications
Topics
Article Type
Display Headline
Antidepressants and Bleeding Risk
Display Headline
Antidepressants and Bleeding Risk
Legacy Keywords
adverse drug effects and interactions, mental health, serotonergic antidepressants, surgery, bleedingadverse drug effects and interactions, mental health, serotonergic antidepressants, surgery, bleeding
Legacy Keywords
adverse drug effects and interactions, mental health, serotonergic antidepressants, surgery, bleedingadverse drug effects and interactions, mental health, serotonergic antidepressants, surgery, bleeding
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

The Right Time for Simvastatin

Article Type
Changed
Display Headline
The Right Time for Simvastatin

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 20(12)
Publications
Page Number
38
Legacy Keywords
simvastatin, statin, high cholesterol, optimal dosingsimvastatin, statin, high cholesterol, optimal dosing
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 20(12)
Issue
Federal Practitioner - 20(12)
Page Number
38
Page Number
38
Publications
Publications
Article Type
Display Headline
The Right Time for Simvastatin
Display Headline
The Right Time for Simvastatin
Legacy Keywords
simvastatin, statin, high cholesterol, optimal dosingsimvastatin, statin, high cholesterol, optimal dosing
Legacy Keywords
simvastatin, statin, high cholesterol, optimal dosingsimvastatin, statin, high cholesterol, optimal dosing
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Rofecoxib: An ADVANTAGE over Naproxen?

Article Type
Changed
Display Headline
Rofecoxib: An ADVANTAGE over Naproxen?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 20(12)
Publications
Page Number
36
Legacy Keywords
rofecoxib, naproxen, ADVANTAGE Study Group, osteoarthritis, rheumatic disease, osteoporosis, arthritisrofecoxib, naproxen, ADVANTAGE Study Group, osteoarthritis, rheumatic disease, osteoporosis, arthritis
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 20(12)
Issue
Federal Practitioner - 20(12)
Page Number
36
Page Number
36
Publications
Publications
Article Type
Display Headline
Rofecoxib: An ADVANTAGE over Naproxen?
Display Headline
Rofecoxib: An ADVANTAGE over Naproxen?
Legacy Keywords
rofecoxib, naproxen, ADVANTAGE Study Group, osteoarthritis, rheumatic disease, osteoporosis, arthritisrofecoxib, naproxen, ADVANTAGE Study Group, osteoarthritis, rheumatic disease, osteoporosis, arthritis
Legacy Keywords
rofecoxib, naproxen, ADVANTAGE Study Group, osteoarthritis, rheumatic disease, osteoporosis, arthritisrofecoxib, naproxen, ADVANTAGE Study Group, osteoarthritis, rheumatic disease, osteoporosis, arthritis
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

New Hope for Advanced AD

Article Type
Changed
Display Headline
New Hope for Advanced AD

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 20(12)
Publications
Page Number
36
Legacy Keywords
Alzheimer's disease, Namenda, memantine, FDA, late-stage, treatment, gerontology, neurologyAlzheimer's disease, Namenda, memantine, FDA, late-stage, treatment, gerontology, neurology
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 20(12)
Issue
Federal Practitioner - 20(12)
Page Number
36
Page Number
36
Publications
Publications
Article Type
Display Headline
New Hope for Advanced AD
Display Headline
New Hope for Advanced AD
Legacy Keywords
Alzheimer's disease, Namenda, memantine, FDA, late-stage, treatment, gerontology, neurologyAlzheimer's disease, Namenda, memantine, FDA, late-stage, treatment, gerontology, neurology
Legacy Keywords
Alzheimer's disease, Namenda, memantine, FDA, late-stage, treatment, gerontology, neurologyAlzheimer's disease, Namenda, memantine, FDA, late-stage, treatment, gerontology, neurology
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

New Antibiotic Approved for Skin Infection

Article Type
Changed
Display Headline
New Antibiotic Approved for Skin Infection

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 20(12)
Publications
Topics
Page Number
36
Legacy Keywords
antibiotics, cyclic lipopeptide antibacterial agents, cubicin, skin infections, gram-positive microorganisms, FDAantibiotics, cyclic lipopeptide antibacterial agents, cubicin, skin infections, gram-positive microorganisms, FDA
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 20(12)
Issue
Federal Practitioner - 20(12)
Page Number
36
Page Number
36
Publications
Publications
Topics
Article Type
Display Headline
New Antibiotic Approved for Skin Infection
Display Headline
New Antibiotic Approved for Skin Infection
Legacy Keywords
antibiotics, cyclic lipopeptide antibacterial agents, cubicin, skin infections, gram-positive microorganisms, FDAantibiotics, cyclic lipopeptide antibacterial agents, cubicin, skin infections, gram-positive microorganisms, FDA
Legacy Keywords
antibiotics, cyclic lipopeptide antibacterial agents, cubicin, skin infections, gram-positive microorganisms, FDAantibiotics, cyclic lipopeptide antibacterial agents, cubicin, skin infections, gram-positive microorganisms, FDA
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Pioglitazone: Beyond Glycemic Control

Article Type
Changed
Display Headline
Pioglitazone: Beyond Glycemic Control

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 20(12)
Publications
Page Number
36
Legacy Keywords
pioglitazone, glycemic control, C-reactive protein, pulse wave velocitypioglitazone, glycemic control, C-reactive protein, pulse wave velocity
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 20(12)
Issue
Federal Practitioner - 20(12)
Page Number
36
Page Number
36
Publications
Publications
Article Type
Display Headline
Pioglitazone: Beyond Glycemic Control
Display Headline
Pioglitazone: Beyond Glycemic Control
Legacy Keywords
pioglitazone, glycemic control, C-reactive protein, pulse wave velocitypioglitazone, glycemic control, C-reactive protein, pulse wave velocity
Legacy Keywords
pioglitazone, glycemic control, C-reactive protein, pulse wave velocitypioglitazone, glycemic control, C-reactive protein, pulse wave velocity
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Considerations in Simplifying HAART

Article Type
Changed
Display Headline
Considerations in Simplifying HAART

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 20(11)
Publications
Topics
Page Number
30
Legacy Keywords
HIV, HAART, protease inhibitor, nevirapine, efavirenz, abacavirHIV, HAART, protease inhibitor, nevirapine, efavirenz, abacavir
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 20(11)
Issue
Federal Practitioner - 20(11)
Page Number
30
Page Number
30
Publications
Publications
Topics
Article Type
Display Headline
Considerations in Simplifying HAART
Display Headline
Considerations in Simplifying HAART
Legacy Keywords
HIV, HAART, protease inhibitor, nevirapine, efavirenz, abacavirHIV, HAART, protease inhibitor, nevirapine, efavirenz, abacavir
Legacy Keywords
HIV, HAART, protease inhibitor, nevirapine, efavirenz, abacavirHIV, HAART, protease inhibitor, nevirapine, efavirenz, abacavir
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Antisuicide Advantage for Lithium?

Article Type
Changed
Display Headline
Antisuicide Advantage for Lithium?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 20(11)
Publications
Topics
Page Number
30
Legacy Keywords
mental health, preventive medicine, suicide, lithium, bipolar disordermental health, preventive medicine, suicide, lithium, bipolar disorder
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 20(11)
Issue
Federal Practitioner - 20(11)
Page Number
30
Page Number
30
Publications
Publications
Topics
Article Type
Display Headline
Antisuicide Advantage for Lithium?
Display Headline
Antisuicide Advantage for Lithium?
Legacy Keywords
mental health, preventive medicine, suicide, lithium, bipolar disordermental health, preventive medicine, suicide, lithium, bipolar disorder
Legacy Keywords
mental health, preventive medicine, suicide, lithium, bipolar disordermental health, preventive medicine, suicide, lithium, bipolar disorder
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Cautions About Clarithromycin for H. Pylori

Article Type
Changed
Display Headline
Cautions About Clarithromycin for H. Pylori

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 20(11)
Publications
Page Number
24
Legacy Keywords
antibiotic resistance, gastroenterology, clarithromycin, h. pyloriantibiotic resistance, gastroenterology, clarithromycin, h. pylori
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 20(11)
Issue
Federal Practitioner - 20(11)
Page Number
24
Page Number
24
Publications
Publications
Article Type
Display Headline
Cautions About Clarithromycin for H. Pylori
Display Headline
Cautions About Clarithromycin for H. Pylori
Legacy Keywords
antibiotic resistance, gastroenterology, clarithromycin, h. pyloriantibiotic resistance, gastroenterology, clarithromycin, h. pylori
Legacy Keywords
antibiotic resistance, gastroenterology, clarithromycin, h. pyloriantibiotic resistance, gastroenterology, clarithromycin, h. pylori
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

NSAIDs and Parkinson's Disease

Article Type
Changed
Display Headline
NSAIDs and Parkinson's Disease

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 20(11)
Publications
Topics
Page Number
24
Legacy Keywords
neurology, preventive medicine, nonaspirin NSAIDs, parkinson'sneurology, preventive medicine, nonaspirin NSAIDs, parkinson's
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 20(11)
Issue
Federal Practitioner - 20(11)
Page Number
24
Page Number
24
Publications
Publications
Topics
Article Type
Display Headline
NSAIDs and Parkinson's Disease
Display Headline
NSAIDs and Parkinson's Disease
Legacy Keywords
neurology, preventive medicine, nonaspirin NSAIDs, parkinson'sneurology, preventive medicine, nonaspirin NSAIDs, parkinson's
Legacy Keywords
neurology, preventive medicine, nonaspirin NSAIDs, parkinson'sneurology, preventive medicine, nonaspirin NSAIDs, parkinson's
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media